tm
Seeing Is Believing
tm
Seeing Is Believing
CUE is currently covered by 1 analysts with an average price target of $4. This is a potential upside of $4.29 (-88.68%) from yesterday's end of day stock price of $35.35.
Cue Biopharma's activity chart (see below) currently has 20 price targets and 20 ratings on display. The stock rating distribution of CUE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 84.52% with an average time for these price targets to be met of 530.17 days.
Highest price target for CUE is $4, Lowest price target is $4, average price target is $4.
Most recent stock forecast was given by from LUCID CAPITAL on 25-Aug-2025. First documented stock forecast 22-Jan-2020.
Currently out of the existing stock ratings of CUE, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Aug-2025
$4
$-21.39 (-84.25%)
10 months 14 days ago
(25-Aug-2025)
1/1 (100%)
$3.18 (387.80%)
242
Buy Since 22-Jan-2020
$2
$-23.39 (-92.12%)
$2
1 years 2 months 24 days ago
(15-Apr-2025)
7/7 (100%)
$1.2 (150.00%)
714
Buy Since 13-Mar-2024
$4
$-21.39 (-84.25%)
$6
1 years 7 months 24 days ago
(15-Nov-2024)
2/2 (100%)
$2.75 (220.00%)
649
Buy Since 09-Apr-2020
$4
$-21.39 (-84.25%)
$8
1 years 10 months 19 days ago
(20-Aug-2024)
4/4 (100%)
$3.14 (365.12%)
700
Buy Since 21-Nov-2022
$3
$-22.39 (-88.18%)
$3
1 years 10 months 19 days ago
(20-Aug-2024)
5/5 (100%)
$2.14 (248.84%)
839
What is CUE (Cue Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on CUE (Cue Biopharma) with a proven track record?
Which analyst has the most public recommendations on CUE (Cue Biopharma)?
Which analyst is the currently most bullish on CUE (Cue Biopharma)?
Which analyst is the currently most reserved on CUE (Cue Biopharma)?
